Denosumab Reduces Type II Diabetes Risk The British Medical Journal has published a matched cohort analysis demonstrating that adults receiving denosumab had a lower risk of NIDDM compared with those taking oral bisphosphonates for osteoporosis. https://t.co/7SMjp258gX https://t.co/SAUmahwV9J